Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression.
about
Mammary gland developmentAnti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidencesOn hormone action in the mammary glandHormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal WomenWhat Is Breast in the Bone?Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification.Early dissemination seeds metastasis in breast cancer.Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary glandProgesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk.A local basis for progesterone action during mammary tumorigenesis - no longer RANK and fileFrom the ranks of mammary progesterone mediators, RANKL takes the spotlightAberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors.The biology of progesterone receptor in the normal mammary gland and in breast cancerCripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.A bioluminescence reporter mouse that monitors expression of constitutively active β-cateninNotch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitorHormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epitheliumER and PR signaling nodes during mammary gland development.Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesisProgesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells.The innovative medicines initiative: a public private partnership model to foster drug discovery.New insights into lineage restriction of mammary gland epithelium using parity-identified mammary epithelial cells.RANKL inhibition: a promising novel strategy for breast cancer treatment.Estrogen and progesterone in normal mammary gland development and in cancer.Endocrine hormones and local signals during the development of the mouse mammary gland.Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort.Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.Progesterone/RANKL is a major regulatory axis in the human breast.
P2860
Q24629797-2AC33537-0A5D-453B-A051-4A2605A4ADD3Q26863493-0CABF280-8F09-4BC5-89D6-61A5DCDF6B80Q26995172-1BD5FBA9-F5A4-431A-B02D-7725B60D65CAQ28077637-BB99E118-9559-4513-A113-02929651ADE3Q28078337-A095A14A-C913-481B-979E-BEB848B98013Q33559178-57863286-4DC6-4982-98D3-601ACAC68757Q33562263-524AB2B9-E4DF-4404-AE8A-5B12CB740F2DQ33610623-C344710E-B926-47B3-BE5F-B0A6169D06D0Q34321877-4A1ABABE-655D-48C8-82CB-43E5D2007C56Q34549156-9E46F3E3-BD26-424A-B7EF-30E55BF65444Q35029498-7A455722-2A26-4AF5-9B5B-FB3299CC9315Q35659426-FC5349CD-A2B1-437F-BFC9-DE7ACDD61288Q35659971-F80638CC-EFF7-4A0E-8629-AFED9C8B173CQ35868802-8958BEAC-60C0-4484-BA23-BF8B495CB5EEQ36240642-C1147DC2-9B37-40E5-8989-38F3691FB9A9Q36273402-6254424C-BD34-476B-8672-E862FF0F2BD0Q36295368-27F865F7-D0CA-4939-81CC-F02E654AEBAEQ36382641-418A520C-98C9-48A1-9BC0-F68B8A13006DQ36903215-5F369E00-E9A8-42BD-BC19-EAAB2DB97209Q36924384-D34FAC83-B915-4DB5-92D6-E69782063AD0Q37207611-3F74DE76-C50A-498E-A487-D5F254BF7823Q37249108-E906DEAA-8850-4DE4-93FA-B0E7B193775BQ37655104-AB115024-E394-43CF-93CE-35260BF97D42Q37690101-83521F32-A57D-4899-B243-33DD63C7612FQ37865171-C016A84C-86FA-4FD1-820A-9937A70C3782Q37901428-5005C775-4E2A-46A1-B87D-5612C61DFBCFQ38341899-B6EEB056-B627-4897-A39D-C0DF857574B2Q38590446-6AA03F91-0343-4803-B546-258AB8B1878EQ38682103-7FF19A82-F01C-4122-852F-84807A100CD7Q47250561-EDB0D03C-883B-48A0-8D43-9402320DC86CQ51042996-37A0F6E4-BB23-4AFD-BC1D-37D1AD958100
P2860
Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeting RANKL to a specific ...... gesterone receptor expression.
@ast
Targeting RANKL to a specific ...... gesterone receptor expression.
@en
Targeting RANKL to a specific ...... gesterone receptor expression.
@nl
type
label
Targeting RANKL to a specific ...... gesterone receptor expression.
@ast
Targeting RANKL to a specific ...... gesterone receptor expression.
@en
Targeting RANKL to a specific ...... gesterone receptor expression.
@nl
prefLabel
Targeting RANKL to a specific ...... gesterone receptor expression.
@ast
Targeting RANKL to a specific ...... gesterone receptor expression.
@en
Targeting RANKL to a specific ...... gesterone receptor expression.
@nl
P2093
P2860
P356
P1433
P1476
Targeting RANKL to a specific ...... ogesterone receptor expression
@en
P2093
Atish Mukherjee
John P Lydon
Selma M Soyal
P2860
P304
P356
10.1096/FJ.10-157982
P407
P577
2010-07-06T00:00:00Z